
Paul N. Schacknow MD PhD
Glaucoma Related
Consultant in Glaucoma East Florida Eye Institute
Join to view full profile
509 SE Riverside DrSte 302Stuart, FL 34994
Phone+1 772-287-9000
Fax+1 772-287-0507
Dr. Schacknow is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paul Schacknow is an ophthalmologist based in Stuart, FL, specializing in glaucoma and related conditions. He completed his medical education at the University of Miami Leonard M. Miller School of Medicine and further specialized through a residency at Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical School, followed by a fellowship at Sutter Health/California Pacific Medical Center. Dr. Schacknow has been serving as a Clinical Full Professor at Nova Southeastern since 2003. His professional interests include cataract surgery and glaucoma drainage implant surgery. He has authored publications on glaucoma management, including "Clinical Glaucoma Care: The Essentials." His contributions have been recognized with awards from the American Academy of Ophthalmology and other notable organizations.
Education & Training
Sutter Health/California Pacific Medical CenterFellowship, Ophthalmology, 1987 - 1988
Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Ophthalmology, 1984 - 1987
MetroWest Medical CenterInternship, Transitional Year, 1983 - 1984
University of Miami Leonard M. Miller School of MedicineClass of 1983
City University of New YorkPh.D., Experimental Psychology, 1970 - 1976
Certifications & Licensure
FL State Medical License 1989 - 2028
CA State Medical License 1987 - 2020
MA State Medical License 1983 - 2009
AL State Medical License 1988 - 2001
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- LEO Continuing Education Recognition Award American Academy of Ophthalmology, 2007
- Who's Who in Medicine and Healthcare - 6th Edition 2006
- Achievement Award American Academy of Ophthalmology, 2005
Publications & Presentations
PubMed
- Sudden Cardiac Death at Home: Potential Lives Saved With Fully Automated External Defibrillators.Lawrence J Gessman, Paul N Schacknow, Ralph G Brindis
Annals of Emergency Medicine. 2024-01-01 - 186 citationsA multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucomaPaul P. Lee, John G. Walt, John Doyle, Sameer Kotak, Stacy J. Evans
Archives of Ophthalmology. 2006-01-01 - 22 citationsA persistency and economic analysis of latanoprost, bimatoprost, or beta-blockers in patients with open-angle glaucoma or ocular hypertension.Douglas G. Day, Paul N. Schacknow, Elizabeth D. Sharpe, John C. Ellyn, John C. Kulze
Journal of Ocular Pharmacology and Therapeutics. 2004-10-21
Journal Articles
- Association Between Intraocular Pressure Variation and Glaucoma Progression: Data from a United States Chart ReviewLee, PP et al. and the Glaucoma Care Study Group (including Schacknow, PN), American Journal of Ophthalmology, 1/1/2007
- Travoprost 0004% With And Without Benzalkonium Chloride: A Comparison Of Safety And EfficacyLewis, RA et al. and the Travoprost BAC-free Study Group (including Schacknow, PN), J of Glaucoma, 1/1/2007
- The Safety And Intraocular Pressure-Lowering Efficacy Of Brimonidine Tartrate 015% Preserved With Polyquaternium-1Whitson, J and the Brimonidine 0.15% Study Group (including Schacknow, PN), Ophthalmology, 1/1/2006
Books/Book Chapters
Abstracts/Posters
- A Comparison of Travoprost 0.004% / Timolol 0.5% Ophthalmic Solution And The Concomitant Administration Of Travatan And Timolol 0.5%Hughes, BA, et al, and the Travoprost 0.004% / Timolol 0.5% Study Group (including Schacknow, PN), Association for Research in Vision and Ophthalmology, Annual Meeting, Fort Lauderdale, FL, 1/28/2004
- Three Month Comparison Of The Safety And Efficacy Of Travoprost 0.004% / Timolol 0.5% Ophthalmic Solution To Travatan And Timolol 0.5%Barnebey, HS, et al. and the Travoprost 0.004% / Timolol 0.5% Study Group (including Schacknow, PN), Association for Research in Vision and Ophthalmology, Annual Meeting, Fort Lauderdale, FL, 1/26/2004
- An Analysis Of The Intraocular Pressure Lowering Efficacy Of Travoprost In Patients On Multiple Therapy With Only A Fixed Combination Of Dorzolamide / Timolol Replaced.Pryzdryga, J, Schacknow, PN and the TRAVATAN START Study Group, 19th Congress of the Asia - Pacific Academy of Ophthalmology (APAO), Bangkok, Thailand, 1/29/2003
Lectures
- Glaucoma Management in the Age of GenericsPonce, Puerto Rico - 1/28/2011
- Ocular Surface Disease Prevalence Among Glaucoma PatientsEpic Hotel, Miami, FL - 1/24/2011
- A Comparison Of BAK-Free Glaucoma TherapiesEpic Hotel, Miami, FL - 1/24/2011
Other
- Prescribing Generics. (Expert interview)Schacknow, PN, Glaucoma Management, Vol.1 # 1, p. 13 (Vindico Medical Education)
Thorofare, NJ - 1/15/2011 - Topical CAIs are effective adjuncts to prostaglandins. (Telephone interview-article)Schacknow, PN, Ocular Surgery News (by Erin Boyle)
Thorofare, NJ - 1/15/2007 - Balancing Power and Control in Glaucoma TherapyCrandall, AS, Barneby, H, Cuneliffe, I, Miglior, S, Pryzdryga, J, Schacknow, PN, Teus, M, Ocular Surgery News, Europe/Asia-Pacific Edition
1/1/2003
Press Mentions
Glaucoma 360 Reaches Milestones in Search of Glaucoma CureJanuary 29th, 2016
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: